Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) for Adults Aged 60 Years and Older

NCT05765773 is registered in ClinicalTrials.gov with Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products as lead sponsor.

NCT NCT05765773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05765773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) for Adults Aged 60 Years and Older
Lead sponsor
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2021
Completion date
May 19, 2023
Enrollment
200 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid-19, vaccine